STOK
NASDAQ · Biotechnology
Stoke Therapeutics Inc
$28.05
-0.38 (-1.34%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+78.9% upside
Low Target
$29.72
Average Target
$50.17
High Target
$68.67
Current Price
$28.05
Current
$28.05
$28.05
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Scenario Analysis
Bear Case
$29.72
6.0%
Low target
Base Case
$50.17
+78.9%
Avg target
Bull Case
$68.67
+144.8%
High target
Risk/Reward
24.3x
Highly favorable
Price in Context
52-Week High
$40.22
-30.3% from high
52-Week Low
$20.32
+38.0% from low
Target vs 52W High
$50.17
+24.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |